Literature DB >> 26743858

Increased risk of psychosis in patients with hearing impairment: Review and meta-analyses.

Mascha M J Linszen1, Rachel M Brouwer2, Sophie M Heringa2, Iris E Sommer2.   

Abstract

Several studies suggest hearing impairment as a risk factor for psychosis. Hearing impairment is highly prevalent and potentially reversible, as it can be easily diagnosed and sometimes improved. Insight in the association between hearing impairment and psychosis can therefore contribute to prevention of psychosis. This paper provides meta-analyses of all epidemiologic evidence on the association between hearing impairment and psychosis and summarizes mechanisms that potentially underlie this relationship. Meta-analyses showed an increased risk of hearing impairment on all psychosis outcomes, such as hallucinations (OR 1.40(95%CI 1.18-1.65; n=227,005)), delusions (OR 1.55(95%CI 1.36-1.78; n=250,470)), psychotic symptoms (OR 2.23(95%CI 1.83-2.72; n=229,647) and delirium (OR 2.67(95%CI 2.05-3.48; n=12,432). Early exposure to hearing impairment elevated the risk of later development of schizophrenia (OR 3.15(95%CI 1.25-7.95; n=50,490)). Potential mechanisms underlying this association include loneliness, diminished theory of mind, disturbances of source monitoring and top-down processing and deafferentiation. Early assessment and treatment of hearing impairment in patients with (high risk of) psychosis may be essential in psychosis treatment and prevention.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Delirium; Delusion; Hallucination; Hearing impairment; Hearing loss; Mechanisms; Meta-analysis; Psychosis; Psychosis prevention; Review; Risk factor; Schizophrenia

Mesh:

Year:  2015        PMID: 26743858     DOI: 10.1016/j.neubiorev.2015.12.012

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  22 in total

1.  Primary care of adults with intellectual and developmental disabilities: 2018 Canadian consensus guidelines.

Authors:  William F Sullivan; Heidi Diepstra; John Heng; Shara Ally; Elspeth Bradley; Ian Casson; Brian Hennen; Maureen Kelly; Marika Korossy; Karen McNeil; Dara Abells; Khush Amaria; Kerry Boyd; Meg Gemmill; Elizabeth Grier; Natalie Kennie-Kaulbach; Mackenzie Ketchell; Jessica Ladouceur; Amanda Lepp; Yona Lunsky; Shirley McMillan; Ullanda Niel; Samantha Sacks; Sarah Shea; Katherine Stringer; Kyle Sue; Sandra Witherbee
Journal:  Can Fam Physician       Date:  2018-04       Impact factor: 3.275

2. 

Authors:  William F Sullivan; Heidi Diepstra; John Heng; Shara Ally; Elspeth Bradley; Ian Casson; Brian Hennen; Maureen Kelly; Marika Korossy; Karen McNeil; Dara Abells; Khush Amaria; Kerry Boyd; Meg Gemmill; Elizabeth Grier; Natalie Kennie-Kaulbach; Mackenzie Ketchell; Jessica Ladouceur; Amanda Lepp; Yona Lunsky; Shirley McMillan; Ullanda Niel; Samantha Sacks; Sarah Shea; Katherine Stringer; Kyle Sue; Sandra Witherbee
Journal:  Can Fam Physician       Date:  2018-04       Impact factor: 3.275

3.  The Relevance of Emotion Regulation in Explaining Why Social Exclusion Triggers Paranoia in Individuals at Clinical High Risk of Psychosis.

Authors:  Tania M Lincoln; Johanna Sundag; Björn Schlier; Anne Karow
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

4.  What causes psychosis? An umbrella review of risk and protective factors.

Authors:  Joaquim Radua; Valentina Ramella-Cravaro; John P A Ioannidis; Abraham Reichenberg; Nacharin Phiphopthatsanee; Taha Amir; Hyi Yenn Thoo; Dominic Oliver; Cathy Davies; Craig Morgan; Philip McGuire; Robin M Murray; Paolo Fusar-Poli
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

Review 5.  Clinical and neurocognitive aspects of hallucinations in Alzheimer's disease.

Authors:  Mohamad El Haj; Jean Roche; Renaud Jardri; Dimitrios Kapogiannis; Karim Gallouj; Pascal Antoine
Journal:  Neurosci Biobehav Rev       Date:  2017-02-21       Impact factor: 8.989

Review 6.  [How the brain perceives the world in old age with all senses].

Authors:  Jan Peter Thomas; Christiane Völter; Rainer Wirth; Rainer Guthoff; Martin Grunwald; Thomas Hummel
Journal:  Z Gerontol Geriatr       Date:  2021-09-07       Impact factor: 1.281

7.  Hearing Loss, Psychiatric Symptoms, and Cognitive Decline: An Increasingly Important Triad in Older Adults.

Authors:  Katharine K Brewster; Bret R Rutherford
Journal:  Am J Geriatr Psychiatry       Date:  2020-10-29       Impact factor: 4.105

8.  Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study.

Authors:  Lotta-Katrin Pries; Agustin Lage-Castellanos; Philippe Delespaul; Gunter Kenis; Jurjen J Luykx; Bochao D Lin; Alexander L Richards; Berna Akdede; Tolga Binbay; Vesile Altinyazar; Berna Yalinçetin; Güvem Gümüş-Akay; Burçin Cihan; Haldun Soygür; Halis Ulaş; Eylem Şahin Cankurtaran; Semra Ulusoy Kaymak; Marina M Mihaljevic; Sanja Andric Petrovic; Tijana Mirjanic; Miguel Bernardo; Bibiana Cabrera; Julio Bobes; Pilar A Saiz; María Paz García-Portilla; Julio Sanjuan; Eduardo J Aguilar; José Luis Santos; Estela Jiménez-López; Manuel Arrojo; Angel Carracedo; Gonzalo López; Javier González-Peñas; Mara Parellada; Nadja P Maric; Cem Atbaşoğlu; Alp Ucok; Köksal Alptekin; Meram Can Saka; Celso Arango; Michael O'Donovan; Bart P F Rutten; Jim van Os; Sinan Guloksuz
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

9.  Psychotic symptoms and sensory impairment: Findings from the 2014 adult psychiatric morbidity survey.

Authors:  Natalie Shoham; Gemma Lewis; Joseph Hayes; Sally McManus; Reza Kiani; Traolach Brugha; Paul Bebbington; Claudia Cooper
Journal:  Schizophr Res       Date:  2019-09-01       Impact factor: 4.662

Review 10.  Hearing impairment and diverse health outcomes : An umbrella review of meta-analyses of observational studies.

Authors:  Mike Trott; Lee Smith; Tao Xiao; Nicola Veronese; Ai Koyanagi; Louis Jacob; Guillermo F Lopez-Sanchez; Yvonne Barnett; Shahina Pardhan
Journal:  Wien Klin Wochenschr       Date:  2021-06-22       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.